Malignant News and Research

RSS

Discovery of how communication between cancer cells is controlled

The discovery, by scientists at Monash University and the Sloan Kettering Cancer Centre in New York, of how communication between cancer cells is controlled has promised new treatment options for malignant tumours.

30 Oct 2005

Measurement of telomerase activity in urine appears useful for detection of bladder cancer in men

The incidence of human bladder cancer has greatly increased over the last few decades, with more than 60,000 new cases diagnosed each year in the United States alone, and now represents the 4th most common malignancy in men and the 10th most common in women, according to background information in the article.

25 Oct 2005

New treatments suggest that cancer is on the run!

People suffering from cancer will be encouraged by a cluster of recent reports on successful new treatments for several different forms of cancer.

24 Oct 2005

Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

Patients with multiple myeloma suffer from a malignant proliferation of plasma cells in their bone marrow. The standard treatment for this form of cancer is high-dose chemotherapy and transplantation of one's own blood-producing adult stem cells; however, this aggressive treatment wipes out the mature immune-system cells of patients – leaving them vulnerable to infection.

20 Oct 2005

Treating malignant melanoma of the uvea with radiation therapy can spare patients from significant vision loss

Treating a rare form of eye cancer with radiation therapy can spare patients from significant vision loss, according to new research at Wake Forest University Baptist Medical Center.

18 Oct 2005

People who carry a mutation in the melanoma susceptibility gene CDKN2A have a much lower risk of melanoma

In addition, most familial clusters of melanoma occur in families without identifiable mutations in this gene, according to a new study that appears in the October 19 issue of the Journal of the National Cancer Institute.

18 Oct 2005

New tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation

Scientists have developed a new tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation, therapies that are widely used for the treatment of cancer.

17 Oct 2005

Discovery could help make cellular immunotherapy safer

Researchers at the University of Michigan's Comprehensive Cancer Center have discovered the secret weapon behind the most powerful form of cancer immunotherapy known to medicine.

16 Oct 2005

E-cadherin, that cellular touch so important in cancer

E-cadherin is a molecule involved in adhesion between epithelial cells that also seems to have a protective role in cancer, since its loss is associated with tumour progression and metastases formation in a series of different cancers.

16 Oct 2005

Chromosomes in the nucleus of the cell carry the material of heredity, or genes

Abnormal cell division that yields cells with an extra set of chromosomes can initiate the development of tumors in mice, researchers at Dana-Farber Cancer Institute have shown, validating a controversial theory about cancer causation put forth by a scientific visionary nearly 100 years ago.

12 Oct 2005

New monoclonal antibody that targets immune system B cells shows promise for treating leukemias

In studies with mice, treatment with a new monoclonal antibody that targets immune system B cells has shown considerable promise for treating leukemias, autoimmune diseases and transplant rejection, according to immunologists at Duke University Medical Center.

11 Oct 2005

CT colonography best choice for regular screening for cancer

Colorectal cancer is the second leading cause of cancer deaths in most developed countries. Screening for colorectal malignancies and polyps (which frequently become cancerous) has been shown to lower the number of deaths from cancer. Most cancer societies and preventive task forces recommend regular screening for cancer of the colon.

10 Oct 2005

Important milestone towards more individually targeted and effective treatments for cancer patients

The research team has now identified crucial genes in a range of common cancers that have been reported to predict a patient's response to treatment. This follows the team's earlier success in studying a tumor suppressor gene associated with acute lymphoblastic leukaemia (ALL) in children.

9 Oct 2005

Veggies reduce the risk of developing lung cancer in smokers

Eating vegetables and other foods that have weak estrogen-like activity appears to reduce the risk of developing lung cancer in smokers - as well as in non-smokers, say researchers at The University of Texas M. D. Anderson Cancer Center.

27 Sep 2005

Combining optical tomography with standard ultrasound imaging can help distinguish early-stage breast cancer

A new study shows that combining a technology called optical tomography with standard ultrasound imaging can help distinguish early-stage breast cancer from non-cancerous lesions--and potentially reduce the number of breast biopsies performed. The study appears in the October issue of the journal Radiology.

27 Sep 2005

Work absence after breast cancer diagnosis

Breast cancer is a very common malignancy with serious health effects that often involves women in the prime of their lives. Drolet and colleagues report on the work experience of women recently diagnosed with breast cancer.

27 Sep 2005

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

...a discovery that could pave the way for more effective cancer treatments.

27 Sep 2005

A new, less toxic way to treat malignant melanoma

A new, less toxic way to treat malignant melanoma (skin cancer) is being developed by medicinal chemists at Reading University. They have produced a range of prodrugs: compounds that offer the potential to be converted to toxic molecules only within the vicinity of tumours. These prodrugs aim to reduce the toxicity of treatment.

26 Sep 2005

Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells

The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies.

26 Sep 2005

Link between tissue tension and tumor formation

Most investigations into cancer have focused on chemical signals, but a new research study provides rare insight into how mechanical force can regulate cellular behavior.

20 Sep 2005

Malignant News and Research

Discovery of how communication between cancer cells is controlled

Measurement of telomerase activity in urine appears useful for detection of bladder cancer in men

New treatments suggest that cancer is on the run!

Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

Treating malignant melanoma of the uvea with radiation therapy can spare patients from significant vision loss

People who carry a mutation in the melanoma susceptibility gene CDKN2A have a much lower risk of melanoma

New tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation

Discovery could help make cellular immunotherapy safer

E-cadherin, that cellular touch so important in cancer

Chromosomes in the nucleus of the cell carry the material of heredity, or genes

New monoclonal antibody that targets immune system B cells shows promise for treating leukemias

CT colonography best choice for regular screening for cancer

Important milestone towards more individually targeted and effective treatments for cancer patients

Veggies reduce the risk of developing lung cancer in smokers

Combining optical tomography with standard ultrasound imaging can help distinguish early-stage breast cancer

Work absence after breast cancer diagnosis

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

A new, less toxic way to treat malignant melanoma

Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells

Link between tissue tension and tumor formation

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News